A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Condition(s):Small Lymphocytic Lymphoma; Chronic Lymphocytic LeukemiaLast Updated:June 6, 2023Completed